TidalSense
Respiratory diagnostics, Cambridge
AI-powered breath-test device for rapid COPD diagnosis. It raised £14.2m in its Series B in July 2026. It has 0 roles open, 0 of them in the UK.
Backed by Airstream Capital, BGF, Cross-Border Impact Ventures and Foresight Group.
On the Home Office register of licensed visa sponsors.
Open roles over time
Hiring momentum
Roles per weekNo data yet.
In the news
All 7 stories- Fundingapp.dealroom.co, 31 Aug 2026TidalSense raises £16M to scale AI diagnostic device for COPD
- OtherTech.eu, 24 Aug 2026COPD diagnosis is broken. TidalSense wants to fix it with 75 seconds of breathing
- FundingFemTech World, 6 Aug 2026TidalSense raises £14m to expand five-minute COPD test across NHS
- OtherHealthcare Today, 5 Aug 2026Capital raising in healthtech: TidalSense, Regenerus Laboratories and Pharmacy2U
- FundingCambridge Independent, 31 Jul 2026TidalSense raises £14m to roll out N-Tidal Diagnose COPD device
- FundingUKTN, 24 Jul 2026TidalSense secures £14.2m for AI breath test